BioStock: Aptahem's founder is back – now as Chairman of the Board
On September 25, Bert Junno was elected Chairman of the Board of the biotech company Aptahem. As a founder of several companies in the industry, including Aptahem in 2014, Junno brings extensive experience from business development, drug development and fund raising in the resource-intensive industry. In order to finance the continued development towards clinical studies, Aptahem is currently raising just over 32 MSEK in a rights issue of units. BioStock reached out to Junno who shared his visions for the company.
Read the full interview with Bert Junno at biostock.se:
This is a pressrelease from BioStock - Connecting Innovation & Capital. https://www.biostock.se/